Opportunity for efficiency in clinical development: An overview of adaptive clinical trial designs and innovative machine learning tools, with examples from the cardiovascular field-Reference-Cited by-同舟云学术

Opportunity for efficiency in clinical development: An overview of adaptive clinical trial designs and innovative machine learning tools, with examples from the cardiovascular field

Published:2021-06 Issue: Volume:105 Page:106397
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Sverdlov Oleksandr,Ryeznik Yevgen,Wong Weng Kee

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference140 articles.

1. Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls;Bauer;Stat. Med.,2016

2. Adaptive designs for clinical trials;Bhatt;N. Engl. J. Med.,2016

3. Adaptive designs: the swiss army knife among clinical trial designs?;Bretz;Clin. Trials,2017

4. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency;Collignon;Trials,2018

5. Adaptive designs in clinical trials: why use them, and how to run and report them;Pallmann;BMC Med.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a conceptual framework for defining trial efficiency;PLOS ONE;2024-05-23

2. Global Regulatory Requirements Applicable for PROTACs;PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics;2024

3. An Overview of Adaptive Designs and Some of Their Challenges, Benefits, and Innovative Applications;Journal of Medical Internet Research;2023-10-16

4. A systematic review of randomised controlled trials with adaptive and traditional group sequential designs – applications in cardiovascular clinical trials;BMC Medical Research Methodology;2023-09-07

5. The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies;Current Oncology Reports;2023-07-04